Parallax Volatility Advisers’s TherapeuticsMD TXMD Stock Holding History

Parallax Volatility Advisers’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-52	Closed	-$1K	–	3205
2021 Q4	$1K	Hold	52	–	–	﹤0.01%	1984
2021 Q3	$2K	Buy	+52	New	+$2.31K	﹤0.01%	1968
2020 Q1	–	Hold	0	–	–	–	2727
2019 Q4	–	Sell	-13	Closed	-$1.87K	–	2655
2019 Q3	$2K	Buy	+13	New	+$1.83K	﹤0.01%	2224
2019 Q1	–	Hold	0	–	–	–	4041
2018 Q4	–	Sell	-62	Closed	-$15.1K	–	3962
2018 Q3	$20K	Sell	62 -120	-66%	-$36.8K	﹤0.01%	2136
2018 Q2	$57K	Sell	182 -572	-76%	-$175K	﹤0.01%	1535
2018 Q1	$184K	Buy	754 +262	+53%	+$73.5K	﹤0.01%	1266
2017 Q4	$149K	Buy	+492	New	+$137K	﹤0.01%	2510

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Parallax Volatility Advisers's TXMD Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 52 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in TXMD in Q4 2017 and held it in 7 quarters. The position peaked at $184K in Q1 2018. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

Parallax Volatility Advisers reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
Parallax Volatility Advisers sold 52 TherapeuticsMD shares in Q1 2022, an estimated $1K.
Parallax Volatility Advisers first reported a position in TherapeuticsMD in Q4 2017 and held it in 7 quarters.
Parallax Volatility Advisers's TherapeuticsMD position peaked at $184K in Q1 2018.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.